University of Miami — Coral Gables, Florida

Public research footprint of University of Miami, compiled from the ClinicalTrials.gov public registry.

317

Registered studies

194

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Malignant Solid Neoplasm · Recurrent Malignant Female Reproductive System Neoplasm · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT05554328 — Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Miami?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.